Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna, F Caponigro - OncoTargets and therapy, 2009 - Taylor & Francis
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
被引用次数：8 相关文章

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna, F Caponigro - OncoTargets and Therapy, 2009 - dovepress.com
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
[PDF] semanticscholar.org

[PDF][PDF] recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri - OncoTargets and Therapy, 2009 - pdfs.semanticscholar.org
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
[HTML] nih.gov

[HTML][HTML] Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna, F Caponigro - OncoTargets and therapy, 2009 - ncbi.nlm.nih.gov
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck.

F Perri, F Longo, F Ionna, F Caponigro - Oncotargets and Therapy, 2009 - europepmc.org
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna… - OncoTargets and …, 2009 - search.proquest.com
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
[PDF] archive.org

[PDF][PDF] recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri - OncoTargets and Therapy, 2009 - scholar.archive.org
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna… - OncoTargets and …, 2009 - pubmed.ncbi.nlm.nih.gov
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
[PDF] psu.edu

[PDF][PDF] recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri - OncoTargets and Therapy, 2009 - Citeseer
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …
[PDF] academia.edu

[PDF][PDF] recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri - OncoTargets and Therapy, 2009 - academia.edu
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …